The DOI matches its Crossref record, with a small difference in title or year.
Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action.
Abstract
We set out to determine whether the central action of growth hormone (GH) secretagogues to induce Fos protein expression in the arcuate nucleus is influenced by central somatostatin action. Conscious male rats were injected i.v. with 100 µg sandostatin (octreotide, a long-acting somatostatin analogue) or saline, 10 min before an i.v. injection of either 50 µg GH-releasing peptide (GHRP-6), 50 µg MK-0677 (a non-peptide GH secretagogue) or saline. In a separate study, conscious male rats were injected i.c.v. with either 2 µg sandostatin or artificial cerebrospinal fluid (aCSF) vehicle 20 min before an i.v. injection of 50 µg GHRP-6. In all studies, rats were anaesthetized 90 min following GH secretagogue injection, perfused with fixative and the brains processed for the immunocytochemical detection of Fos protein. The number of Fos-positive nuclei detected in the arcuate nucleus of the i.v. sandostatin/i.v. GHRP-6 treated rats (28 ± 5 nuclei/section) and the i.v. sandostatin/i.v. MK-0677-injected rats (8 ± 2 nuclei/section) was significantly less than the i.v. saline/i.v. GHRP-6-treated group (56 ± 5 nuclei/section) and the i.v. saline/ i.v. MK-0677-treated group (20 ± 2 nuclei/section) respectively. Intracerebroventricular sandostatin injection attenuated the GHRP-6-induced Fos response, from 53 ± 6 nuclei/section in the i.c.v. aCSF/i.v. GHRP-6 group, to 39 ± 5 nuclei/section in the i.c.v. sandostatin/i.v. GHRP-6 group. Thus, the central action of GH secretagogues to induce Fos protein expression in the arcuate nucleus appears to be subject to central inhibitory control by somatostatin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity
Muccioli, G., Tschöp, M., Papotti, M., Deghenghi, R., Heiman, M., & Ghigo, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01432-2 · Cited by 385
Growth hormone-releasing peptide (GHRP)
Bowers, C. Y. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050257 · Cited by 154
Metadata
- Authors
- Dickson, S. L., Viltart, O., Bailey, A. R. T., & Leng, G.
- Affiliations
- University of Cambridge (GB)
- Université de Lille (FR)
- University of Edinburgh (GB)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-04-09
- Volume
- 66
- Issue
- 3
- Pages
- 188-194
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2053676156
- Cited by
- 42
- References
- 0
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cooley's Anemia Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- growth hormone secretagogues, Fos expression, arcuate nucleus, somatostatin, octreotide, neuroendocrine feedback, hypothalamus
- MeSH terms
- Animals, Arcuate Nucleus of Hypothalamus, Hormone Antagonists, Indoles, Injections, Intravenous, Injections, Intraventricular, Male, Nerve Tissue Proteins, Oligopeptides, Somatostatin, Growth Hormone, Growth Hormone-Releasing Hormone, Spiro Compounds, Octreotide, Proto-Oncogene Proteins c-fos, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. https://app.cochat.ai/papers/10.1159/000127237
- The paper
- Dickson, S. L., Viltart, O., Bailey, A. R. T., & Leng, G. (2008). Attenuation of the growth hormone secretagogue induction of Fos protein in the rat arcuate nucleus by central somatostatin action. Neuroendocrinology. https://doi.org/10.1159/000127237
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.